These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18559656)

  • 1. Diabetes in patients with idiopathic Parkinson's disease.
    Becker C; Brobert GP; Johansson S; Jick SS; Meier CR
    Diabetes Care; 2008 Sep; 31(9):1808-12. PubMed ID: 18559656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
    Brauer R; Wei L; Ma T; Athauda D; Girges C; Vijiaratnam N; Auld G; Whittlesea C; Wong I; Foltynie T
    Brain; 2020 Oct; 143(10):3067-3076. PubMed ID: 33011770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.
    Mokhles MM; Trifirò G; Dieleman JP; Haag MD; van Soest EM; Verhamme KM; Mazzaglia G; Herings R; Luise Cd; Ross D; Brusselle G; Colao A; Haverkamp W; Schade R; Camp Gv; Zanettini R; Sturkenboom MC
    Pharmacol Res; 2012 Mar; 65(3):358-64. PubMed ID: 22123498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease and risk of prostate cancer: A Danish population-based case-control study, 1995-2010.
    Jespersen CG; Nørgaard M; Borre M
    Cancer Epidemiol; 2016 Dec; 45():157-161. PubMed ID: 27838564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
    Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
    Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.
    Becker C; Jick SS; Meier CR
    Drug Saf; 2008; 31(5):399-407. PubMed ID: 18422380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and the risk of developing Parkinson's disease in Denmark.
    Schernhammer E; Hansen J; Rugbjerg K; Wermuth L; Ritz B
    Diabetes Care; 2011 May; 34(5):1102-8. PubMed ID: 21411503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing challenges to finding people with Parkinson's disease for epidemiological studies: a comparison of population-level case ascertainment methods.
    Harris MA; Koehoorn M; Teschke K
    Parkinsonism Relat Disord; 2011 Jul; 17(6):464-9. PubMed ID: 21531606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and the risk of Parkinson's disease.
    Hu G; Jousilahti P; Bidel S; Antikainen R; Tuomilehto J
    Diabetes Care; 2007 Apr; 30(4):842-7. PubMed ID: 17251276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnea and risk of Parkinson's disease: a population-based cohort study.
    Chen JC; Tsai TY; Li CY; Hwang JH
    J Sleep Res; 2015 Aug; 24(4):432-7. PubMed ID: 25810019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Callaghan RC; Cunningham JK; Sajeev G; Kish SJ
    Mov Disord; 2010 Oct; 25(14):2333-9. PubMed ID: 20737543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of Parkinson's disease in cataract patients: a population-based cohort study.
    Lai SW; Lin CL; Liao KF; Chang-Ou KC
    Parkinsonism Relat Disord; 2015 Jan; 21(1):68-71. PubMed ID: 25466927
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Alvarado-Esquivel C; Méndez-Hernández EM; Salas-Pacheco JM; Ruano-Calderón LÁ; Hernández-Tinoco J; Arias-Carrión O; Sánchez-Anguiano LF; Castellanos-Juárez FX; Sandoval-Carrillo AA; Liesenfeld O; Ramos-Nevárez A
    BMJ Open; 2017 Feb; 7(2):e013019. PubMed ID: 28193849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.
    Molsberry S; Bjornevik K; Hughes KC; Zhang ZJ; Jeanfavre S; Clish C; Healy B; Schwarzschild M; Ascherio A
    J Parkinsons Dis; 2020; 10(3):1011-1021. PubMed ID: 32250318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Prevalence of Polyneuropathy in Parkinson's Disease Patients: An Observational Study.
    Conradt C; Guo D; Miclea A; Nisslein T; Ismail C; Chatamra K; Andersohn F
    J Parkinsons Dis; 2018; 8(1):141-144. PubMed ID: 29154292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.
    Brauer R; Bhaskaran K; Chaturvedi N; Dexter DT; Smeeth L; Douglas I
    PLoS Med; 2015 Jul; 12(7):e1001854. PubMed ID: 26196151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with levodopa and risk for malignant melanoma.
    Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
    Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young onset Parkinson's disease.
    Quinn N; Critchley P; Marsden CD
    Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.